ITTO910999A1 - Derivati dell'1-3-diossolano quali agenti per la riduzione del colesterolo - Google Patents

Derivati dell'1-3-diossolano quali agenti per la riduzione del colesterolo

Info

Publication number
ITTO910999A1
ITTO910999A1 IT000999A ITTO910999A ITTO910999A1 IT TO910999 A1 ITTO910999 A1 IT TO910999A1 IT 000999 A IT000999 A IT 000999A IT TO910999 A ITTO910999 A IT TO910999A IT TO910999 A1 ITTO910999 A1 IT TO910999A1
Authority
IT
Italy
Prior art keywords
lower alkyl
hydrogen
cholesterol
agents
reduction
Prior art date
Application number
IT000999A
Other languages
English (en)
Inventor
Pamela M Burton
David C Swinney
Keith A M Walker
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of ITTO910999A0 publication Critical patent/ITTO910999A0/it
Publication of ITTO910999A1 publication Critical patent/ITTO910999A1/it
Application granted granted Critical
Publication of IT1250362B publication Critical patent/IT1250362B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
ITTO910999A 1990-12-20 1991-12-19 Derivati dell'1-3-diossolano quali agenti per la riduzione del colesterolo IT1250362B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/633,599 US5158949A (en) 1990-12-20 1990-12-20 1,3-dioxolane derivatives as cholesterol-lowering agents

Publications (3)

Publication Number Publication Date
ITTO910999A0 ITTO910999A0 (it) 1991-12-19
ITTO910999A1 true ITTO910999A1 (it) 1992-06-21
IT1250362B IT1250362B (it) 1995-04-07

Family

ID=24540306

Family Applications (1)

Application Number Title Priority Date Filing Date
ITTO910999A IT1250362B (it) 1990-12-20 1991-12-19 Derivati dell'1-3-diossolano quali agenti per la riduzione del colesterolo

Country Status (21)

Country Link
US (1) US5158949A (it)
EP (1) EP0492474B1 (it)
JP (1) JPH04308588A (it)
KR (1) KR920011484A (it)
AT (1) ATE149495T1 (it)
AU (1) AU650079B2 (it)
CA (1) CA2058068A1 (it)
DE (1) DE69124956T2 (it)
DK (1) DK0492474T3 (it)
FI (1) FI916018A (it)
GR (1) GR3022740T3 (it)
HU (2) HUT61998A (it)
IE (1) IE914442A1 (it)
IL (1) IL100430A (it)
IT (1) IT1250362B (it)
MX (1) MX9102703A (it)
NO (1) NO179006C (it)
NZ (1) NZ241068A (it)
PT (1) PT99859A (it)
TW (1) TW230208B (it)
ZA (1) ZA9110019B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208331A (en) * 1992-06-18 1993-05-04 Syntex (U.S.A.) Inc. Process for preparing 1,3-dioxolane derivatives
US5274108A (en) * 1992-06-18 1993-12-28 Syntex (U.S.A.) Inc. Process for preparing 1,3-dioxolane derivatives
KR100331609B1 (ko) * 1995-04-21 2002-11-18 성 렬 류 신규한시스-튜불라졸유도체및그의제조방법
KR100704710B1 (ko) * 1999-10-29 2007-04-09 주식회사 중외제약 간 섬유화 억제작용을 나타내는 벤조[3,4-ｄ]1,3-디옥솔란 유도체
WO2008151437A1 (en) * 2007-06-14 2008-12-18 Osta Biotechnologies Heme-oxygenase inhibitors and use of the same in the treatment of cancer and diseases of the central nervous system
EP3519390A1 (en) * 2016-09-29 2019-08-07 Bayer CropScience Aktiengesellschaft 1,5-substituted imidazole derivatives as fungicides for crop protection.
EA202190092A1 (ru) 2018-06-21 2021-05-18 Юманити Терапьютикс, Инк. Композиции и способы лечения и профилактики неврологических расстройств

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4078071A (en) * 1976-03-08 1978-03-07 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkyl imidazoles
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4321272A (en) * 1980-08-25 1982-03-23 Syntex (U.S.A.) Inc. Derivatives of substituted N-alkylimidazoles
EP0052905B1 (en) * 1980-11-24 1984-10-03 Janssen Pharmaceutica N.V. Novel (2-aryl-4-phenylthioalkyl-1,3-dioxolan-2-yl-methyl)azole derivatives
US4490540A (en) * 1981-09-14 1984-12-25 Janssen Pharmaceutica N.V. (2-Aryl-4-phenylthioalkyl-1,3-dioxolan-2-ylmethyl)azole derivatives
US4359475A (en) * 1981-12-21 1982-11-16 Syntex (U.S.A.) Inc. Thioketal substituted N-alkyl imidazoles
US4375474A (en) * 1982-02-11 1983-03-01 Syntex (U.S.A.) Inc. Dioxalane containing imidazole compounds, compositions and use
DK305884A (da) * 1983-06-24 1984-12-25 Yamanouchi Pharma Co Ltd Phenoxyderivat, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende et saadant derivat
US4518607A (en) * 1983-07-18 1985-05-21 Syntex (U.S.A.) Inc. Male oral contraceptive N-alkylimidazole derivatives, compositions, and method of use therefor
US4940799A (en) * 1987-07-20 1990-07-10 Ciba-Geigy Corporation Preparation of the diastereomeric mixture 2R,4S-1-[2-(2,4-dichlorophenyl)-4-n-propyl-1,3-dioxolan-2-ylmethyl]-1H-1,2,4-triazole
AU614818B2 (en) * 1988-03-28 1991-09-12 Janssen Pharmaceutica N.V. 2-imidazolylmethyl-1,3-dioxolanyl methylthiophenyl carbamate derivatives and their use as antineoplastic agents

Also Published As

Publication number Publication date
JPH04308588A (ja) 1992-10-30
ZA9110019B (en) 1993-06-21
MX9102703A (es) 1992-06-01
NO179006B (no) 1996-04-09
HU210718A9 (en) 1995-06-28
PT99859A (pt) 1992-12-31
NO915036L (no) 1992-06-22
GR3022740T3 (en) 1997-06-30
KR920011484A (ko) 1992-07-24
IL100430A0 (en) 1992-09-06
EP0492474A1 (en) 1992-07-01
HU914024D0 (en) 1992-03-30
HUT61998A (en) 1993-03-29
DE69124956T2 (de) 1997-06-12
AU650079B2 (en) 1994-06-09
IE914442A1 (en) 1992-07-01
AU8990591A (en) 1992-06-25
IT1250362B (it) 1995-04-07
FI916018A0 (fi) 1991-12-19
CA2058068A1 (en) 1992-06-21
EP0492474B1 (en) 1997-03-05
ATE149495T1 (de) 1997-03-15
DE69124956D1 (de) 1997-04-10
DK0492474T3 (da) 1997-03-24
TW230208B (it) 1994-09-11
FI916018A (fi) 1992-06-21
IL100430A (en) 1997-03-18
NO179006C (no) 1996-07-17
ITTO910999A0 (it) 1991-12-19
NO915036D0 (no) 1991-12-19
US5158949A (en) 1992-10-27
NZ241068A (en) 1996-12-20

Similar Documents

Publication Publication Date Title
ES8708224A1 (es) Un procedimiento para la preparacion de nuevos derivados de carbazolona
FI943142A0 (fi) Amidi- ja ureajohdannaiset, joilla on veren korkeita kolesteroliarvoja vastustava vaikutus, niiden valmistus ja terapeuttiset käytöt
MX9304215A (es) Nuevos derivados piperidinicos del bencimidazol.
ES2095277T3 (es) 6,7-dihidro-3-fenil-1,2-benzoisoxazol-4(5h)-onas y -oles, un procedimiento para su preparacion y su uso como medicamentos.
PE34996A1 (es) Nuevo derivado de pirrocarbazol
ITTO910999A1 (it) Derivati dell'1-3-diossolano quali agenti per la riduzione del colesterolo
ATE119773T1 (de) Thiazolidin-derivate mit antihypertensiver aktivität und deren therapeutische anwendung.
ES2094551T3 (es) Procedimiento para preparar derivados del 1,3-dioxolano.
DK633989D0 (da) Laegemiddelforstadier til 3,4-hydroxy-benzoyloxypropanolaminer og deres anvendelse
ES2135383T3 (es) Pirido(3,4-b)pirrolo(1,2-e)(1,4,5)oxadiazepinas y compuestos analogos relacionados, un procedimiento para su preparacion y su uso como medicamentos.
DE69904427D1 (de) Benzothiophenderivate als antithrombotische Mitteln und Zwischenprodukte

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961231